These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3498087)

  • 1. Nifedipine inhibits granulocyte activation during cardiopulmonary bypass.
    Riegel W; Spillner G; Schlosser V; Hörl WH
    Klin Wochenschr; 1987 Jul; 65(12):581. PubMed ID: 3498087
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma levels of main granulocyte components during cardiopulmonary bypass.
    Riegel W; Spillner G; Schlosser V; Hörl WH
    J Thorac Cardiovasc Surg; 1988 Jun; 95(6):1014-9. PubMed ID: 2836662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers.
    Hörl WH; Riegel W; Schollmeyer P; Rautenberg W; Neumann S
    Clin Nephrol; 1986 Jun; 25(6):304-7. PubMed ID: 3015463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes.
    Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Ringdal MA; Videm V
    Ann Thorac Surg; 1995 Dec; 60(6):1755-61. PubMed ID: 8787476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activation of complement during cardiopulmonary bypass--comparative study using 4 different oxygenators].
    Soejima K; Koyanagi H; Endo M; Hashimoto A; Imai Y
    Nihon Kyobu Geka Gakkai Zasshi; 1987 Feb; 35(2):200-4. PubMed ID: 3495614
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma levels of main granulocyte components in patients dialyzed with polycarbonate and cuprophan membranes.
    Hörl WH; Riegel W; Schollmeyer P
    Nephron; 1987; 45(4):272-6. PubMed ID: 3035392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte activation during haemodialysis in the absence of complement activation: inhibition by calcium channel blockers.
    Haag-Weber M; Schollmeyer P; Hörl WH
    Eur J Clin Invest; 1988 Aug; 18(4):380-5. PubMed ID: 3139423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution.
    Moore FD; Warner KG; Assousa S; Valeri CR; Khuri SF
    Ann Surg; 1988 Jul; 208(1):95-103. PubMed ID: 3260474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of granulocyte proteins during cardiopulmonary bypass: effect of different pharmacological interventions.
    Riegel W; Spillner G; Schlosser V; Lang K; Hörl WH
    Adv Exp Med Biol; 1988; 240():391-7. PubMed ID: 2854361
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension.
    Slotman GJ; Burchard KW; Williams JJ; D'Arezzo A; Yellin SA
    Surgery; 1986 Jun; 99(6):744-51. PubMed ID: 3520916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.
    Chenoweth DE; Cooper SW; Hugli TE; Stewart RW; Blackstone EH; Kirklin JW
    N Engl J Med; 1981 Feb; 304(9):497-503. PubMed ID: 7453783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of methylprednisolone, prednisolone and dexamethasone on granulocyte function and complement activation.
    Redl H; Lamche H; Paul E; Schiesser A; Schlag G
    Prog Clin Biol Res; 1987; 236B():261-72. PubMed ID: 2441413
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement (C3, C4) consumption in cardiopulmonary bypass, cardioplegia, and protamine administration.
    Chiu RC; Samson R
    Ann Thorac Surg; 1984 Mar; 37(3):229-32. PubMed ID: 6703805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Simultaneous studies of granulocyte phagocytosis, serum immunoglobulins, acute phase proteins and the 3d complement component in patients with malignant tumors].
    Friedrich A; Walther E; Bomski B; Glass W
    Arch Geschwulstforsch; 1984; 54(2):137-52. PubMed ID: 6203497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease.
    Gardinali M; Padalino P; Vesconi S; Calcagno A; Ciappellano S; Conciato L; Chiara O; Agostoni A; Nespoli A
    Arch Surg; 1992 Oct; 127(10):1219-24. PubMed ID: 1417490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators.
    Cavarocchi NC; Pluth JR; Schaff HV; Orszulak TA; Homburger HA; Solis E; Kaye MP; Clancy MS; Kolff J; Deeb GM
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):252-8. PubMed ID: 3511328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation and neutropenia occurring during cardiopulmonary bypass.
    Hammerschmidt DE; Stroncek DF; Bowers TK; Lammi-Keefe CJ; Kurth DM; Ozalins A; Nicoloff DM; Lillehei RC; Craddock PR; Jacob HS
    J Thorac Cardiovasc Surg; 1981 Mar; 81(3):370-7. PubMed ID: 6970304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dialyzer geometry on granulocyte and complement activation.
    Schaefer RM; Heidland A; Hörl WH
    Am J Nephrol; 1987; 7(2):121-6. PubMed ID: 3496792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement and the damaging effects of cardiopulmonary bypass.
    Westaby S
    Thorax; 1983 May; 38(5):321-5. PubMed ID: 6603674
    [No Abstract]   [Full Text] [Related]  

  • 20. Release of granulocyte elastase and complement changes during hysterectomy.
    Wanscher M; Knudsen F; Antonsen S; Hansen SH
    Scand J Clin Lab Invest; 1989 May; 49(3):255-8. PubMed ID: 2787048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.